{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T11:14:34Z","timestamp":1782126874026,"version":"3.54.5"},"reference-count":74,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,25]],"date-time":"2022-10-25T00:00:00Z","timestamp":1666656000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/R021406\/1"],"award-info":[{"award-number":["MR\/R021406\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012041","name":"Versus Arthritis","doi-asserted-by":"publisher","award":["20623"],"award-info":[{"award-number":["20623"]}],"id":[{"id":"10.13039\/501100012041","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012041","name":"Versus Arthritis","doi-asserted-by":"publisher","award":["21425"],"award-info":[{"award-number":["21425"]}],"id":[{"id":"10.13039\/501100012041","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.jbc.2022.102644","type":"journal-article","created":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T21:10:21Z","timestamp":1666818621000},"page":"102644","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Salt-inducible kinase 2 regulates fibrosis during bleomycin-induced lung injury"],"prefix":"10.1016","volume":"298","author":[{"given":"Manuel","family":"van Gijsel-Bonnello","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola J.","family":"Darling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8419-8832","authenticated-orcid":false,"given":"Samuele","family":"Di Carmine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Marchesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Thomson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristopher","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariola","family":"Kurowska-Stolarska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry J.","family":"McSorley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8135-1958","authenticated-orcid":false,"given":"J. Simon C.","family":"Arthur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbc.2022.102644_bib1","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/s12931-021-01791-z","article-title":"Global incidence and prevalence of idiopathic pulmonary fibrosis","volume":"22","author":"Maher","year":"2021","journal-title":"Respir. Res."},{"key":"10.1016\/j.jbc.2022.102644_bib2","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1056\/NEJMra1705751","article-title":"Idiopathic pulmonary fibrosis","volume":"378","author":"Lederer","year":"2018","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.jbc.2022.102644_bib3","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1016\/S0140-6736(17)30866-8","article-title":"Idiopathic pulmonary fibrosis","volume":"389","author":"Richeldi","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.jbc.2022.102644_bib4","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.rmed.2018.12.015","article-title":"Inflammation and immunity in IPF pathogenesis and treatment","volume":"147","author":"Heukels","year":"2019","journal-title":"Respir. Med."},{"key":"10.1016\/j.jbc.2022.102644_bib5","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12931-018-0730-2","article-title":"Idiopathic pulmonary fibrosis: pathogenesis and management","volume":"19","author":"Sgalla","year":"2018","journal-title":"Respir. Res."},{"key":"10.1016\/j.jbc.2022.102644_bib6","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.immuni.2016.02.015","article-title":"Macrophages in tissue repair, regeneration, and fibrosis","volume":"44","author":"Wynn","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.jbc.2022.102644_bib7","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11926-018-0725-5","article-title":"Macrophages, wound healing, and fibrosis: recent insights","volume":"20","author":"Smigiel","year":"2018","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.jbc.2022.102644_bib8","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12964-018-0300-8","article-title":"M2 macrophages promote myofibroblast differentiation of LR-MSCs and are associated with pulmonary fibrogenesis","volume":"16","author":"Hou","year":"2018","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.jbc.2022.102644_bib9","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1164\/rccm.200509-1518OC","article-title":"A\u00a0vicious circle of alveolar macrophages and fibroblasts perpetuates pulmonary fibrosis via CCL18","volume":"173","author":"Prasse","year":"2006","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.jbc.2022.102644_bib10","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.pupt.2018.07.002","article-title":"Use of animal models in IPF research","volume":"51","author":"Carrington","year":"2018","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.jbc.2022.102644_bib11","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1021\/cr030117g","article-title":"Antitumor antibiotics: bleomycin, enediynes, and mitomycin","volume":"105","author":"Galm","year":"2005","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jbc.2022.102644_bib12","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.phrs.2015.04.012","article-title":"Bleomycin in the setting of lung fibrosis induction: from biological mechanisms to counteractions","volume":"97","author":"Della Latta","year":"2015","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.jbc.2022.102644_bib13","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1164\/rccm.201010-1719OC","article-title":"Ly6Chi monocytes direct alternatively activated profibrotic macrophage regulation of lung fibrosis","volume":"184","author":"Gibbons","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.jbc.2022.102644_bib14","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1164\/rccm.200609-1279OC","article-title":"Important roles for macrophage colony-stimulating factor, CC chemokine ligand 2, and mononuclear phagocytes in the pathogenesis of pulmonary fibrosis","volume":"176","author":"Baran","year":"2007","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.jbc.2022.102644_bib15","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2121098119","article-title":"Nanoparticle targeting of de novo profibrotic macrophages mitigates lung fibrosis","volume":"119","author":"Singh","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2022.102644_bib16","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1084\/jem.20162152","article-title":"Monocyte-derived alveolar macrophages drive lung fibrosis and persist in the lung over the life span","volume":"214","author":"Misharin","year":"2017","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.jbc.2022.102644_bib17","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/mt.2016.36","article-title":"Chop deficiency protects mice against bleomycin-induced pulmonary fibrosis by attenuating M2 macrophage production","volume":"24","author":"Yao","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jbc.2022.102644_bib18","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1096\/fj.14-260182","article-title":"Deletion of ADORA2B from myeloid cells dampens lung fibrosis and pulmonary hypertension","volume":"29","author":"Karmouty-Quintana","year":"2015","journal-title":"FASEB J."},{"key":"10.1016\/j.jbc.2022.102644_bib19","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.immuni.2016.01.001","article-title":"Macrophage Akt1 kinase-mediated mitophagy modulates apoptosis resistance and pulmonary fibrosis","volume":"44","author":"Larson-Casey","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.jbc.2022.102644_bib20","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.4049\/jimmunol.1402377","article-title":"IRAK-M promotes alternative macrophage activation and fibroproliferation in bleomycin-induced lung injury","volume":"194","author":"Ballinger","year":"2015","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jbc.2022.102644_bib21","doi-asserted-by":"crossref","first-page":"14003","DOI":"10.1074\/jbc.M117.802066","article-title":"Increased levels of Gab1 and Gab2 adaptor proteins skew interleukin-4 (IL-4) signaling toward M2 macrophage-driven pulmonary fibrosis in mice","volume":"292","author":"Guo","year":"2017","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2022.102644_bib22","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.4049\/jimmunol.1303463","article-title":"Myeloid-specific disruption of tyrosine phosphatase Shp2 promotes alternative activation of macrophages and predisposes mice to pulmonary fibrosis","volume":"193","author":"Tao","year":"2014","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jbc.2022.102644_bib23","article-title":"Sustained PI3K Activation exacerbates BLM-induced Lung Fibrosis via activation of pro-inflammatory and pro-fibrotic pathways","volume":"6","author":"Kral","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jbc.2022.102644_bib24","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.tem.2018.09.007","article-title":"The salt-inducible kinases: emerging metabolic regulators","volume":"29","author":"Sakamoto","year":"2018","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.jbc.2022.102644_bib25","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.tem.2018.08.004","article-title":"Salt-inducible kinases: physiology, regulation by cAMP, and therapeutic potential","volume":"29","author":"Wein","year":"2018","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.jbc.2022.102644_bib26","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1042\/BCJ20200502","article-title":"Nuts and bolts of the salt-inducible kinases (SIKs)","volume":"478","author":"Darling","year":"2021","journal-title":"Biochem. J."},{"key":"10.1016\/j.jbc.2022.102644_bib27","doi-asserted-by":"crossref","first-page":"4307","DOI":"10.1111\/j.1432-1033.2004.04372.x","article-title":"Salt-inducible kinase-1 represses cAMP response element-binding protein activity both in the nucleus and in the cytoplasm","volume":"271","author":"Katoh","year":"2004","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.jbc.2022.102644_bib28","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.cell.2004.09.015","article-title":"The CREB coactivator TORC2 functions as a calcium- and cAMP-sensitive coincidence detector","volume":"119","author":"Screaton","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.jbc.2022.102644_bib29","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1074\/jbc.M117.805424","article-title":"Differential control of Toll-like receptor 4-induced interleukin-10 induction in macrophages and B cells reveals a role for p90 ribosomal S6 kinases","volume":"293","author":"Sutavani","year":"2018","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2022.102644_bib30","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/ni.1644","article-title":"The kinases MSK1 and MSK2 act as negative regulators of Toll-like receptor signaling","volume":"9","author":"Ananieva","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jbc.2022.102644_bib31","doi-asserted-by":"crossref","first-page":"565","DOI":"10.4049\/jimmunol.1202462","article-title":"PGE(2) induces macrophage IL-10 production and a regulatory-like phenotype via a protein kinase A-SIK-CRTC3 pathway","volume":"190","author":"MacKenzie","year":"2013","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jbc.2022.102644_bib32","doi-asserted-by":"crossref","first-page":"16986","DOI":"10.1073\/pnas.1215450109","article-title":"Phosphorylation of CRTC3 by the salt-inducible kinases controls the interconversion of classically activated and regulatory macrophages","volume":"109","author":"Clark","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2022.102644_bib33","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1042\/BCJ20160646","article-title":"Inhibition of SIK2 and SIK3 during differentiation enhances the anti-inflammatory phenotype of macrophages","volume":"474","author":"Darling","year":"2017","journal-title":"Biochem. J."},{"key":"10.1016\/j.jbc.2022.102644_bib34","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1042\/BJ20141165","article-title":"The clinically approved drugs dasatinib and bosutinib induce anti-inflammatory macrophages by inhibiting the salt-inducible kinases","volume":"465","author":"Ozanne","year":"2015","journal-title":"Biochem. J."},{"key":"10.1016\/j.jbc.2022.102644_bib35","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11926-010-0142-x","article-title":"Tyrosine kinase inhibitors in the treatment of systemic sclerosis: from animal models to clinical trials","volume":"13","author":"Iwamoto","year":"2011","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.jbc.2022.102644_bib36","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1183\/09031936.00149614","article-title":"The role of tyrosine kinases in the pathogenesis of idiopathic pulmonary fibrosis","volume":"45","author":"Grimminger","year":"2015","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.jbc.2022.102644_bib37","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1056\/NEJMoa1402584","article-title":"Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis","volume":"370","author":"Richeldi","year":"2014","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.jbc.2022.102644_bib38","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1042\/CS20190249","article-title":"Application of nintedanib and other potential anti-fibrotic agents in fibrotic diseases","volume":"133","author":"Liu","year":"2019","journal-title":"Clin. Sci. (Lond)"},{"key":"10.1016\/j.jbc.2022.102644_bib39","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s40265-014-0335-0","article-title":"Nintedanib: first global approval","volume":"75","author":"McCormack","year":"2015","journal-title":"Drugs"},{"key":"10.1016\/j.jbc.2022.102644_bib40","doi-asserted-by":"crossref","first-page":"366","DOI":"10.3109\/08977194.2015.1109511","article-title":"Dasatinib attenuated bleomycin-induced pulmonary fibrosis in mice","volume":"33","author":"Yilmaz","year":"2015","journal-title":"Growth Factors"},{"key":"10.1016\/j.jbc.2022.102644_bib41","doi-asserted-by":"crossref","first-page":"4774","DOI":"10.1158\/0008-5472.CAN-07-6307","article-title":"BIBF 1120: triple angiokinase inhibitor with sustained receptor blockade and good antitumor efficacy","volume":"68","author":"Hilberg","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.jbc.2022.102644_bib42","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1124\/jpet.117.244129","article-title":"Triple angiokinase inhibitor nintedanib directly inhibits tumor cell growth and induces tumor shrinkage via blocking oncogenic receptor tyrosine kinases","volume":"364","author":"Hilberg","year":"2018","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jbc.2022.102644_bib43","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jim.2011.10.013","article-title":"Systematic validation of specific phenotypic markers for in\u00a0vitro polarized human macrophages","volume":"375","author":"Ambarus","year":"2012","journal-title":"J.\u00a0Immunol. Met."},{"key":"10.1016\/j.jbc.2022.102644_bib44","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1084\/jem.176.1.287","article-title":"Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation","volume":"176","author":"Stein","year":"1992","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.jbc.2022.102644_bib45","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1189\/jlb.0304212","article-title":"Macrophage galactose-type C-type lectins as novel markers for alternatively activated macrophages elicited by parasitic infections and allergic airway inflammation","volume":"77","author":"Raes","year":"2005","journal-title":"J.\u00a0Leukoc. Biol."},{"key":"10.1016\/j.jbc.2022.102644_bib46","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1165\/rcmb.2013-0086MA","article-title":"Flow cytometric analysis of macrophages and dendritic cell subsets in the mouse lung","volume":"49","author":"Misharin","year":"2013","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.jbc.2022.102644_bib47","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1172\/JCI42090","article-title":"Epithelium-specific deletion of TGF-beta receptor type II protects mice from bleomycin-induced pulmonary fibrosis","volume":"121","author":"Li","year":"2011","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.jbc.2022.102644_bib48","doi-asserted-by":"crossref","first-page":"L585","DOI":"10.1152\/ajplung.00151.2001","article-title":"Smad3 deficiency attenuates bleomycin-induced pulmonary fibrosis in mice","volume":"282","author":"Zhao","year":"2002","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.jbc.2022.102644_bib49","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1084\/jem.20092054","article-title":"Pathological versus protective functions of IL-22 in airway inflammation are regulated by IL-17A","volume":"207","author":"Sonnenberg","year":"2010","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.jbc.2022.102644_bib50","doi-asserted-by":"crossref","first-page":"567","DOI":"10.4049\/jimmunol.170.1.567","article-title":"Repression of bleomycin-induced pneumopathy by TNF","volume":"170","author":"Kuroki","year":"2003","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jbc.2022.102644_bib51","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1165\/rcmb.2013-0386OC","article-title":"Tumor necrosis factor-alpha accelerates the resolution of established pulmonary fibrosis in mice by targeting profibrotic lung macrophages","volume":"50","author":"Redente","year":"2014","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.jbc.2022.102644_bib52","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1084\/jem.20092121","article-title":"Bleomycin and IL-1beta-mediated pulmonary fibrosis is IL-17A dependent","volume":"207","author":"Wilson","year":"2010","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.jbc.2022.102644_bib53","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.yexmp.2003.12.010","article-title":"IL-10 inhibits inflammation but does not affect fibrosis in the pulmonary response to bleomycin","volume":"76","author":"Kradin","year":"2004","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.jbc.2022.102644_bib54","doi-asserted-by":"crossref","first-page":"4032","DOI":"10.4049\/jimmunol.165.7.4032","article-title":"GM-CSF regulates bleomycin-induced pulmonary fibrosis via a prostaglandin-dependent mechanism","volume":"165","author":"Moore","year":"2000","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jbc.2022.102644_bib55","doi-asserted-by":"crossref","first-page":"5511","DOI":"10.4049\/jimmunol.162.9.5511","article-title":"Neutralization of the CXC chemokine, macrophage inflammatory protein-2, attenuates bleomycin-induced pulmonary fibrosis","volume":"162","author":"Keane","year":"1999","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jbc.2022.102644_bib56","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1165\/rcmb.2007-0364OC","article-title":"Role of the chemokine receptor CXCR2 in bleomycin-induced pulmonary inflammation and fibrosis","volume":"40","author":"Russo","year":"2009","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.jbc.2022.102644_bib57","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1242\/dev.072652","article-title":"SIK3 is essential for chondrocyte hypertrophy during skeletal development in mice","volume":"139","author":"Sasagawa","year":"2012","journal-title":"Development"},{"key":"10.1016\/j.jbc.2022.102644_bib58","doi-asserted-by":"crossref","first-page":"100428","DOI":"10.1016\/j.jbc.2021.100428","article-title":"Salt-inducible kinases are required for the IL-33-dependent secretion of cytokines and chemokines in mast cells","volume":"296","author":"Darling","year":"2021","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2022.102644_bib59","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S2213-2600(20)30330-1","article-title":"Efficacy and safety of nintedanib in patients with systemic sclerosis-associated interstitial lung disease treated with mycophenolate: a subgroup analysis of the SENSCIS trial","volume":"9","author":"Highland","year":"2021","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.jbc.2022.102644_bib60","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/art.41576","article-title":"Effect of nintedanib on lung function in patients with systemic sclerosis-associated interstitial lung disease: further analyses of a randomized, double-blind, placebo-controlled trial","volume":"73","author":"Maher","year":"2021","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jbc.2022.102644_bib61","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1056\/NEJMoa1908681","article-title":"Nintedanib in progressive fibrosing interstitial lung diseases","volume":"381","author":"Flaherty","year":"2019","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.jbc.2022.102644_bib62","doi-asserted-by":"crossref","first-page":"2004538","DOI":"10.1183\/13993003.04538-2020","article-title":"Nintedanib in progressive interstitial lung diseases: data from the whole INBUILD trial","volume":"59","author":"Flaherty","year":"2022","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.jbc.2022.102644_bib63","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s12890-022-01940-0","article-title":"Salt-inducible kinase 2 (SIK2) inhibitor ARN-3236 attenuates bleomycin-induced pulmonary fibrosis in mice","volume":"22","author":"Zou","year":"2022","journal-title":"BMC Pulm. Med."},{"key":"10.1016\/j.jbc.2022.102644_bib64","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1189\/jlb.2A0715-307R","article-title":"SIK inhibition in human myeloid cells modulates TLR and IL-1R signaling and induces an anti-inflammatory phenotype","volume":"99","author":"Lombardi","year":"2016","journal-title":"J.\u00a0Leukoc. Biol."},{"key":"10.1016\/j.jbc.2022.102644_bib65","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-00986-0","article-title":"Salt inducible kinases 2 and 3 are required for thymic T cell development","volume":"11","author":"Nefla","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jbc.2022.102644_bib66","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.immuni.2014.01.006","article-title":"Transcriptome-based network analysis reveals a spectrum model of human macrophage activation","volume":"40","author":"Xue","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.jbc.2022.102644_bib67","doi-asserted-by":"crossref","first-page":"292","DOI":"10.14348\/molcells.2021.0058","article-title":"Development and functions of alveolar macrophages","volume":"44","author":"Woo","year":"2021","journal-title":"Mol. Cells"},{"key":"10.1016\/j.jbc.2022.102644_bib68","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1084\/jem.20131199","article-title":"Alveolar macrophages develop from fetal monocytes that differentiate into long-lived cells in the first week of life via GM-CSF","volume":"210","author":"Guilliams","year":"2013","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.jbc.2022.102644_bib69","article-title":"A\u00a0novel CD206 targeting peptide inhibits bleomycin induced pulmonary fibrosis in mice","author":"Ghebremedhin","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.jbc.2022.102644_bib70","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1182\/blood-2004-12-4943","article-title":"Lack of antigen-specific tissue remodeling in mice deficient in the macrophage galactose-type calcium-type lectin 1\/CD301a","volume":"106","author":"Sato","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jbc.2022.102644_bib71","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/immu.200310005","article-title":"Transgenic mice with hematopoietic and lymphoid specific expression of Cre","volume":"33","author":"de Boer","year":"2003","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jbc.2022.102644_bib72","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1042\/BJ20070797","article-title":"The selectivity of protein kinase inhibitors: a further update","volume":"408","author":"Bain","year":"2007","journal-title":"Biochem. J."},{"key":"10.1016\/j.jbc.2022.102644_bib73","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/1746-6148-9-123","article-title":"Multiparametric and semiquantitative scoring systems for the evaluation of mouse model histopathology--a systematic review","volume":"9","author":"Klopfleisch","year":"2013","journal-title":"BMC Vet. Res."},{"key":"10.1016\/j.jbc.2022.102644_bib74","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1177\/0300985813485099","article-title":"Principles for valid histopathologic scoring in research","volume":"50","author":"Gibson-Corley","year":"2013","journal-title":"Vet. Pathol."}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925822010870?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925822010870?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T00:27:29Z","timestamp":1758241649000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925822010870"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":74,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S0021925822010870"],"URL":"https:\/\/doi.org\/10.1016\/j.jbc.2022.102644","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Salt-inducible kinase 2 regulates fibrosis during bleomycin-induced lung injury","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbc.2022.102644","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 THE AUTHORS. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"102644"}}